Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Down 79.5% in June

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) was the target of a significant drop in short interest during the month of June. As of June 15th, there was short interest totaling 15,401 shares, a drop of 79.5% from the May 31st total of 74,992 shares. Based on an average daily trading volume, of 457,076 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.

Wall Street Analysts Forecast Growth

SGIOY has been the topic of a number of research analyst reports. The Goldman Sachs Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a research note on Monday, June 15th. Zacks Research raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a report on Monday, May 25th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy”.

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

OTCMKTS SGIOY traded up $0.17 during trading on Friday, hitting $8.52. 272,160 shares of the company’s stock traded hands, compared to its average volume of 206,524. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.46 and a current ratio of 1.58. The stock has a market capitalization of $14.50 billion, a price-to-earnings ratio of 10.65, a PEG ratio of 3.20 and a beta of 0.08. Shionogi & Co., Ltd. Unsponsored ADR has a 12-month low of $7.65 and a 12-month high of $12.00. The business has a 50 day moving average of $9.30 and a 200-day moving average of $9.89.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last posted its quarterly earnings results on Tuesday, May 12th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.03. The company had revenue of $881.71 million for the quarter, compared to analyst estimates of $895.52 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 41.08% and a return on equity of 13.56%. As a group, equities research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.81 earnings per share for the current fiscal year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.